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Recent clinical and experimental evidence suggests
that endoplasmic reticulum (ER) stress contributes
to the life-and-death decisions of b cells during the
progression of type 1 and type 2 diabetes. Although
crosstalk between inflammation and ER stress has
been suggested to play a significant role in b cell
dysfunction and death, a key molecule connecting
ER stress to inflammation has not been identified.
Here we report that thioredoxin-interacting protein
(TXNIP) is a critical signaling node that links ER
stress and inflammation. TXNIP is induced by ER
stress through the PERK and IRE1 pathways,
induces IL-1b mRNA transcription, activates IL-1b
production by the NLRP3 inflammasome, and medi-
ates ER stress-mediated b cell death. Collectively,
our results suggest that TXNIP is a potential thera-
peutic target for diabetes and ER stress-related
human diseases such as Wolfram syndrome.
INTRODUCTION
A hallmark of diabetes is reduced functional b cell mass (Donath
and Halban, 2004; Pipeleers et al., 2008). This can be caused by
upregulation of genes inducing cell death or by downregulation
of genes promoting cell survival in b cells. Cell death-promoting
genes that are upregulated in b cells during the progression of
diabetes are promising targets for the development of diabetes
therapeutics.
In patients with type 1 diabetes, destruction of b cells by
inflammatory cytokines including interleukin-1b (IL-1b) leads toCelan absolute deficiency of insulin (Atkinson et al., 2011; Bluestone
et al., 2010). In contrast, type 2 diabetes is a state of relative
insulin deficiency as a result of b cell dysfunction and death
caused by a combination of increased circulating glucose and
saturated fatty acids and development of inflammation (Butler
et al., 2003; Donath and Halban, 2004). Recent evidence sug-
gests that endoplasmic reticulum (ER) stress also plays a role
in the loss of b cells during the progression of type 1 and type
2 diabetes and Wolfram syndrome, a genetic form of diabetes
and neurodegeneration (Eizirik et al., 2008; Oslowski and Urano,
2011).
The crosstalk between inflammation and ER stress has been
suggested to play a significant role in b cell dysfunction and
death (Zhang and Kaufman, 2008). However, a key molecule
that links ER stress to inflammation has not been identified.
Here we report that thioredoxin-interacting protein (TXNIP),
also known as thioredoxin binding protein-2 (TBP-2) and
vitamin-D3 upregulated protein-1 (VDUP1) (Chen and DeLuca,
1994; Nishiyama et al., 1999), is a critical link between ER stress,
inflammation and cell death.
RESULTS
TXNIP Expression Is Increased by ER Stress in b Cells
It has been shown that TXNIP plays a role in b cell death in
diabetes (Chen et al., 2008; Minn et al., 2005), raising the possi-
bility that TXNIP is primarily expressed in b cells as compared to
other cell types of the pancreas. Immunostaining of mouse
pancreas sections with anti-TXNIP antibody together with anti-
insulin or anti-glucagon antibody revealed that TXNIP is highly
expressed in insulin-producing b cells (Figure 1A). To test
whether TXNIP expression is induced by ER stress, we treated
rat insulinoma cells, INS-1 832/13, with chemical ER stress
inducers, thapsigargin and tunicamycin. The results illustratedl Metabolism 16, 265–273, August 8, 2012 ª2012 Elsevier Inc. 265
Figure 1. TXNIP Is Highly Expressed in Pancreatic b Cells and Induced by ER Stress
(A) Mouse pancreata were analyzed by immunohistochemistry. Merged image shows the colocalization of TXNIP and insulin (top) or TXNIP and glucagon
(bottom).
(B) Expression of TXNIP mRNA in INS-1 832/13 cells treated with thapsigargin (TG, 0.25 mM) or tunicamycin (TM, 5 mg/ml).
(C) Expression of TXNIP mRNA in INS-1 832/13 cells treated with glucose (16.7 mM) or human islet polypeptide (hIAPP, 5 mM).
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TXNIP messenger RNA (mRNA) expression levels. We also
tested whether physiological ER stress inducers in b cells could
increase TXNIP expression. It has been shown that pathological
b cell perturbants, such as chronic high glucose and human islet
amyloid polypeptide, can cause ER stress in b cell lines and islets
(Casas et al., 2007; Lipson et al., 2006). As expected, TXNIP
mRNA expression was increased in INS-1 832/13 cells treated
with chronic high glucose and human islet amyloid polypeptide
(Figure 1C). To confirm these observations, we treated mouse
and human primary islets with chemical ER stress inducers,
thapsigargin and tunicamycin. As predicted, TXNIP mRNA
expression was increased in both mouse and human primary
islets by ER stress (Figure 1D). TXNIP protein expression levels
were also increased in INS-1 832/13 cells and human primary
islets treated with tunicamycin and thapsigargin (Figure 1E).
PERK and IRE1a Signaling Pathways Required for TXNIP
Induction under ER Stress
We next wanted to identify the components of the unfolded
protein response (UPR) involved in TXNIP induction by ER stress,
inositol-requiring enzyme 1 (IRE1), PKR-like ER resident kinase
(PERK), and activating transcription factor 6 (ATF6).
In Ire1a knockdown INS-1 832/13 cells, TXNIP expression was
modestly attenuated as compared to control cells under ER
stress conditions (Figure 2A). We also observed that in Ire1a
knockout mouse embryonic fibroblasts (MEFs), mRNA and
protein upregulation of TXNIP were suppressed under ER stress
conditions (Figure 2B). TXNIP expression under ER stress was
also significantly decreased in Perk knockdown INS-1 832/13
cells and Perk knockout MEFs (Figure 2C and 2D). PERK-medi-
ated phosphorylation of eukaryotic initiation factor 2 on Ser51 of
the alpha subunit (eIF2a) is involved in the regulation of gene
expression under ER stress conditions (Harding et al., 1999;
Scheuner et al., 2001). To elucidate the role of eIF2a phosphor-
ylation in TXNIP expression, we used MEFs derived from mice
homozygous for Ser51Ala mutant eIF2a (eIF2a A/A mutant)
(Scheuner et al., 2001). These cells lack eIF2a phosphorylation
under various stress conditions, including ER stress (Back
et al., 2009; Scheuner et al., 2001). Expression levels of
TXNIP mRNA and protein were significantly decreased in eIF2a
A/A mutant cells under ER stress conditions (Figure 2E). Finally,
we studied the possible role of ATF6a in TXNIP upregulation.
However, TXNIP induction in Atf6a knockdown INS-1 832/13
cells and Atf6a knockout MEFs was comparable to wild-type
control cells (Figures 2F and 2G). Collectively, these results
indicate that TXNIP upregulation by ER stress is mediated by
the IRE1a and especially the PERK-eIF2a arms of the UPR in
b cells.
As described above, PERK signaling is critical for TXNIP ex-
pression under ER stress conditions, which prompted us to iden-
tify the downstream signaling molecules of PERK that regulate
TXNIP expression. The UPR regulates gene expression at the(D) Expression of TXNIP mRNA in mouse and human primary islets treated with
(E) Expression of TXNIP protein in INS-1 832/13 cells treated with thapsigargin (TG
treated with tunicamycin (TM, 5 mg/ml) for 24 hr.
n = 3; values are shown as mean ± SD.
Celtranscriptional and posttranscriptional levels (Walter and Ron,
2011). Luciferase reporter constructs containing 1 kb and
1.5 kb of the TXNIP promoter, but not a shorter version contain-
ing 0.5 kb of the TXNIP promoter, were activated by an ER stress
inducer thapsigargin in INS-1 832/13 cells, suggesting that ER
stress-mediated TXNIP upregulation is controlled at the tran-
scription level through a critical site within 1.5 kb of the TXNIP
promoter (Figure 2H). To confirm that PERK signaling is involved
in the transcriptional regulation of TXNIP, we cotransfected the
luciferase reporter construct containing 1.5 kb of the TXNIP
promoter with PERK or GADD34, a negative regulator of PERK
signaling, in INS-1 832/13 cells (Novoa et al., 2001). As expected,
PERK stimulated luciferase production, whereas GADD34 sub-
stantially suppressed luciferase production, especially under
ER stress conditions (Figure 2I). In addition, ectopic expression
of PERK stimulated luciferase production in 293T cells as well
(data not shown). Consistent with these findings, salubrinal, a
chemical inhibitor for eIF2a dephosphorylation, also activated
the luciferase reporter construct containing 1.5 kb of the TXNIP
promoter (Figure 2J). To identify transcription factors that regu-
late TXNIP transcription, we screened transcription factors
known to be regulated by PERK, as well as those that are in-
volved in TXNIP transcription. Based on this screening, we
concluded that ATF4, CHOP, XBP-1, Mondo A, and Foxo1 are
not significant regulators of TXNIP upregulation under ER stress
conditions (data not shown) and elected to focus on ChREBP
and ATF5 (Cha-Molstad et al., 2009; Zhou et al., 2008).
ChREBP is a transcription factor that binds to the carbohy-
drate response element of the LPK gene (Yamashita et al.,
2001) and has been shown to be involved in TXNIP upregulation
by chronic hyperglycemia in INS-1 cells (Minn et al., 2005). To
investigate the role of ChREBP in TXNIP transcription under ER
stress conditions, we transfected INS-1 832/13 cells with the
luciferase reporter construct containing 1.5 kb of the TXNIP
promoter and small interfering RNA (siRNA) directed against
ChREBP and treated the cells with thapsigargin. RNAi-mediated
knockdown of ChREBP suppressed luciferase production under
ER stress conditions (Figure 2K). The efficiency of ChREBP
knockdownwas confirmed by real-time PCR (Figure S1 available
online). We next investigated whether ChREBP directly regulates
TXNIP expression. Chromatin immunoprecipitation (ChIP) anal-
ysis demonstrated that ChREBP binding to the TXNIP promoter
was significantly enhanced by thapsigargin treatment (Fig-
ure 2L and Figure S2). Mlx has been shown to be a functional
heteromeric partner of ChREBP in regulating the expression of
ChREBP target genes (Stoeckman et al., 2004), raising the
possibility that Mlx is also involved in TXNIP expression. As we
expected, Mlx binding to the TXNIP promoter was enhanced
by thapsigargin treatment (Figure 2L). We further confirmed the
relationship between PERK signaling and ChREBP expression.
We found that ChREBP expression was induced by ER stress
and was significantly decreased in Perk knockdown INS-1 832/
13 cells and Perk knockout MEFs (Figure 2M). The efficiency ofthapsigargin (TG, 1 mM) or tunicamycin (TM, 5 mg/ml) for 6 hr.
, 1 mM) for 8 hr or tunicamycin (TM, 5 mg/ml) for 24 hr, and human primary islets
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Figure 2. TXNIP Expression Is Regulated by the IRE1 and PERK-eIF2a Pathways of the UPR
(A) Expression of TXNIP mRNA in INS-1 832/13 cells transfected with control or IRE1a siRNA, and then treated with thapsigargin (TG, 0.5 mM) for 6 hr.
(B) Expression of TXNIP mRNA (left) and protein (right) in wild-type (WT) and Ire1a/ (KO) MEFs treated with thapsigargin (0.5 mM) for 3 hr or untreated.
(C) Expression of TXNIP mRNA in INS-1 832/13 cells transfected with control or PERK siRNA, and then treated with thapsigargin (TG, 0.5 mM) for 6 hr.
(D) Expression of TXNIP mRNA (left) and protein (right) in wild-type (WT) and Perk/ MEFs treated with thapsigargin (0.5 mM) for 3 hr or untreated.
(E) Expression of TXNIP mRNA and protein in wild-type eIF2aS/S or mutant eIF2aA/A MEFs treated with thapsigargin (TG, 0.5 mM) for 3 hr or untreated.
(F) Expression of TXNIPmRNA and protein in INS-1 832/13 cells transfected with control or ATF6a siRNA, and then treated with thapsigargin (TG, 0.5 mM) for 6 hr.
(G) Expression of TXNIP mRNA in wild-type (WT) and Atf6a/ MEFs treated with thapsigargin (0.5 mM) for 3 hr or untreated.
(H) Luciferase reporter assays in INS-1 832/13 cells transiently transfected with TXNIP promoter reporter constructs. Cells were untreated (UT) or treated with
thapsigargin (TG, 0.5 mM) for 6 hr.
(I) Luciferase reporter assays in INS-1 832/13 cells transfected with TXNIP promoter reporter construct carrying 1.5 Kb of TXNIP promoter together with control,
PERK expression, or GADD34 expression vector. Cells were untreated (UT) or treated with thapsigargin (TG, 0.5 mM) for 6 hr.
(J) Luciferase reporter assay in INS-1 832/13 cells transfected with a TXNIP promoter reporter construct carrying 1.5 Kb of TXNIP promoter. Cells were untreated
(UT) or treated with Salubrinal (25 mM) for 24 hr.
(K) Luciferase reporter assays in INS-1 832/13 cells transfected with a TXNIP promoter reporter construct carrying 1.5 Kb of TXNIP promoter together with control
or ChREBP siRNA. Cells were untreated (UT) or treated with thapsigargin (TG, 0.5 mM) for 6 hr.
(L) ChIP assays monitoring binding of ChREBP andMlx to the TXNIP promoter in INS-1 832/13 cells treated with or without thapsigargin (TG, 0.5 mM) for 6 hr. NA,
nonspecific IgG antibody.
(M) Expression of ChREBP mRNA in INS-1 cells transfected with control or PERK siRNA (left), and wild-type and Perk/ MEFs (right) treated with or without
thapsigargin (TG, 0.5 mM) for 6 hr.
(N) Luciferase reporter assays in INS-1 832/13 cells transfected with a TXNIP promoter reporter construct carrying 1.5 Kb of TXNIP promoter together with control
or ATF5 siRNA. Cells were untreated (UT) or treated with thapsigargin (TG, 0.5 mM) for 6 hr.
(O) ChIP assay monitoring binding of ATF5 to the TXNIP promoter in INS-1 832/13 cells treated with or without thapsigargin (TG, 0.5 mM) for 6 hr. NA, nonspecific
IgG antibody.
(P) Expression of ATF5 mRNA in INS-1 832/13 cells transfected with control or PERK siRNA (left), and wild-type and Perk/mouse embryonic fibroblasts (right)
treated with or without thapsigargin (TG, 0.5 mM) for 6 hr.
n = 3; values are shown as mean ± SD. *p < 0.05, **p < 0.01, ***p < 0.001. n.s., not significant. See also Figures S1–S3.
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TXNIP Is a Link between ER Stress and InflammationPerk knockdown was confirmed by real-time PCR (Figure S1). It
has been shown that stimulus-coupling nuclear translocation of
ChREBP contributes to expression of its target genes, raising
the possibility that ChREBP nuclear translocation might be
increased by ER stress. Accordingly, we treated INS-1 832/13
cells with thapsigargin and measured ChREBP levels in cyto-
plasmic and nuclear fractions by immunoblot. As we surmised,
nuclear ChREBP levels were slightly increased by thapsigargin
treatment (Figure S3).
Next we investigated the possible role of ATF5 in ER stress-
mediated TXNIP expression. ATF5 is a member of the ATF/
cAMP response-element binding protein (CREB) family of tran-
scription factors and makes life-or-death decisions in cells
(Persengiev and Green, 2003). It has been shown that PERK-
mediated eIF2a phosphorylation directs ATF5 protein transla-
tion, as well as ATF5 mRNA transcription, and that ATF5 is inte-
gral to the eIF2a kinase response (Zhou et al., 2008), raising the
possibility that ATF5 plays a role in TXNIP upregulation under ER
stress conditions. To test this possibility, we transfected INS-1
832/13 cells with the luciferase reporter construct containing
1.5 kb of the TXNIP promoter and siRNA directed against ATF5
and treated the cells with thapsigargin. RNAi-mediated knock-
down of ATF5 suppressed luciferase production under ER stress
conditions (Figure 2N). The efficiency of ATF5 knockdown was
confirmed by real-time PCR (Figure S1). We further investigated
whether ATF5 is recruited to the TXNIP promoter. ChIP analysis
demonstrated that ATF5 binding to the TXNIP promoter was
enhanced by thapsigargin treatment (Figure 2O and Figure S2).
In addition, ATF5 expression under ER stress was decreased
in Perk knockdown INS-1 832/13 cells and Perk knockout
MEFs (Figure 2P). The efficiency of Perk knockdown was con-
firmed by real-time PCR (Figure S1). Taken together, our results
demonstrate that ChREBP and ATF5 are major regulators of
TXNIP expression under ER stress conditions.
TXNIP Plays a Role in ER Stress-Mediated
Inflammasome Activation, IL-1b Production,
and Apoptosis
It has previously been shown that TXNIP is essential for activa-
tion of the NLRP3 inflammasome and IL-1b production under
oxidative stress (Zhou et al., 2010), raising the possibility that
TXNIP is involved in IL-1b production through NLRP3 under ER
stress conditions. To test this idea, we first analyzed expression
levels of IL-1b and its major downstream target, IL-6, in ER-
stressed b cells. We treated INS-1 832/13 cells with thapsigargin
or tunicamycin and measured IL-1b and IL-6 expression levels
by real-time PCR. Figure 3A illustrates that IL-1b and IL-6
expression was increased by thapsigargin and tunicamycin.
Notably, ectopic expression of GADD34, a negative regulator
for PERK signaling under ER stress, strongly suppressed thapsi-
gargin-mediated IL-1b and IL-6 induction (Figure 3B). Consistent
with these findings was our observation that IL-1b and IL-6
mRNA expression levels were increased by tunicamycin treat-
ment in human primary islets (Figure 3C). To test that IL-1b
produced from islets by ER stress was functional, we treated
human primary islets with an IL-1 receptor antagonist together
with tunicamycin and then measured IL-1b and IL-6 expression
levels. IL-1 receptor antagonist has been shown to suppress
IL-1b signaling and decrease IL-1b and IL-6 mRNA expressionCellevels in b cells (Ehses et al., 2009). We found that IL-1b and
IL-6 upregulation was attenuated in human primary islets treated
with IL-1 receptor antagonist (Figure 3C). These results indicate
that ER stress induces secretion of functional IL-1b in b cells.
To further investigate whether ER stress-mediated IL-1b pro-
duction was dependent on TXNIP, we suppressed TXNIP ex-
pression using short hairpin RNA (shRNA) directed against
TXNIP in INS-1 832/13 cells, treated these cells with thapsigar-
gin, and then measured expression levels of IL-1b and IL-6. As
we expected, IL-1b and IL-6 upregulation was attenuated in
TXNIP knockdown cells as compared to control cells (Fig-
ure 3D). To further confirm this observation, we measured IL-b
and IL-6 expression in primary islets from TXNIP knockout and
control mice treated with thapsigargin. As expected, IL-1b and
IL-6 upregulation by ER stress was attenuated in islets from
TXNIP knockout mice as compared to islets of control mice
(Figure 3E). In support of this conclusion, RNAi-mediated sup-
pression of NLRP3, a major component of inflammasome in-
volved in TXNIP-mediated IL-1b activation (Zhou et al., 2010),
blocked IL-1b and IL-6 upregulation under ER stress conditions
(Figure 3F).
Three experiments verified that ER stress and TXNIP are
involved in inflammasome activation. For this purpose, we elec-
ted to use THP-1 cells inwhich activation levels of inflammasome
can be quantified by multiple methods (Zhou et al., 2010). First,
TXNIP, IL-1b, and IL-6 mRNA expression levels were increased
by both thapsigargin and tunicamycin treatments in THP-1
cells (Figure 3G). Second, IL-1b secretion was increased by
thapsigargin and tunicamycin treatments (Figure 3H). Third, cas-
pase-1 cleavage, a major downstream event of inflammasome
activation (Kuida et al., 1995), was also increased by thapsigargin
and tunicamycin treatment (Figure 3I). Collectively, these results
indicate that ER stress is involved in inflammasome activation
and TXNIP plays a crucial role in ER stress-mediated upregula-
tion and maturation of IL-1b.
TXNIP and IL-1b signaling has a role in b cell death in type 1
and type 2 diabetes, raising the possibility that TXNIP-mediated
IL-1b induction plays a role in ER stress mediated cell death
(Dinarello et al., 2010; Larsen et al., 2007). Therefore, we next
examined the role of TXNIP in b cell death under ER stress condi-
tions. For this purpose, we derived INS-1 832/13 cells in which
we could induce shRNA-mediated suppression of TXNIP using
doxycycline (Figure 4A, left panel). Figure 4A (right panel) dem-
onstrates that suppression of TXNIP protected INS-1 832/13
cells from ER stress-mediated cell death. We also measured
the amount of PI positive cells (i.e., dead cells) when we treated
TXNIP knockdown cells with thapsigargin and tunicamycin.
As expected, suppression of TXNIP decreased the amount of
PI-positive cells under ER stress conditions (Figure 4B). Consis-
tent with this finding was our observation that shRNA-mediated
knockdown of TXNIP increased the viability of INS-1 832/13 cells
under ER stress conditions (Figure 4C). To test the involvement
of IL-1b signaling in ER stress-induced cell death, we treated
human islets with an IL-1 receptor antagonist together with or
without thapsigargin and then monitored cell death. As shown
in Figure 4D, caspase-3 activity induced by thapsigargin was
modestly reduced by the treatment with an IL-1 receptor antag-
onist. Taken together, these results indicate that TXNIP-medi-
ated IL-1b production plays a role in ER stress-mediated b celll Metabolism 16, 265–273, August 8, 2012 ª2012 Elsevier Inc. 269
Figure 3. IL1-b Is Induced by ER Stress and Regulated by TXNIP
(A) IL-1b and IL-6 mRNA expression in human islets treated with thapsigargin
(TG, 1 mM) for 6 hr, tunicamycin (TM, 5 mg/ml) for 6 hr, or untreated.
(B) IL-1b and IL-6 mRNA expression in INS-1 832/13 cells transfected with
control GFP or GADD34 expression plasmid. After 36 hr, cells were untreated
(UT) or treated with thapsigargin (TG, 0.5 mM) for 6 hr.
(C) IL-1b and IL-6 mRNA expression in human islets pretreated with inter-
leukin-1 receptor antagonist (IL1RA, 1 mg/ml) for 24 hr, and then treated with
tunicamycin (TM, 5 mg/ml) for 8 hr.
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against ER stress.
DISCUSSION
The data here demonstrate that TXNIP is a critical signaling node
that links ER stress and IL-1b production. TXNIP expression is
induced by ER stress under the IRE1a and PERK-eIF2a path-
ways of the UPR. Transcriptionally, TXNIP expression is regu-
lated by ChREBP and ATF5. An accompanying manuscript
from Feroz Papa and Scott Oakes in this issue ofCell Metabolism
reveals that IRE1a regulates TXNIP expression at the post-
transcriptional level, which may be complementary to PERK’s
transcriptional control (Lerner et al., 2012). As a result, TXNIP
induces IL-1b production through the activation of NLRP3 in-
flammasome and IL-1b mRNA transcription, leading to b cell
death.
Recent experimental, clinical, and genetic evidence suggests
that ER stress-mediated b cell dysfunction and death contribute
to the pathogenesis of type 1 and type 2 diabetes, as well as
to genetic forms of diabetes such as Wolfram syndrome and
permanent neonatal diabetes (Eizirik et al., 2008; Kaufman,
2011; Oslowski and Urano, 2011; Tersey et al., 2012). However,
the mechanisms involved and pathological contributions remain
elusive. Here we propose that during diabetes, TXNIP expres-
sion is induced through the UPR and leads to b cell inflammation
and apoptosis.
Inflammation is a critical component leading to b cell dys-
function and death in type and type 2 diabetes. (Atkinson
et al., 2011; Bluestone et al., 2010; Corbett et al., 1993; Eizirik
et al., 2009; Larsen et al., 2007). There has been substantial
interest in identifying pathways initiating inflammation. A variety
of inflammatory pathways have been associated with IL-1b
production. However, essential factors initiating inflammation
by IL-1b production in b cells have been elusive. Our findings
unexpectedly revealed that the UPR regulates IL-1b pro-
duction through TXNIP. ER stress-mediated upregulation of
TXNIP leads to IL-1b secretion through inflammasome activa-
tion. Secreted IL-1b is capable of binding to IL-1 receptor on
the b cell surface, which may lead to induction of its own(D) IL-1b and IL-6 mRNA expression in INS-1 832/13 cells stably transduced
with pLenti-TO/shTXNIP, inducible lentivirus expressing shTXNIP. Cells were
cultured with doxycycline (2 mg/ml) to induce shTXNIP or without doxycycline
for 48 hr, then challenged with thapsigargin (TG, 0.5 mM) for 6 hr.
(E) IL-1b and IL-6mRNA expression in primary islets from Txnip/ and control
(WT) mice treated with thapsigargin (TG, 0.5 mM) for 6 hr.
(F) IL-1b and IL-6 mRNA expression in INS-1 832/13 cells transfected with
control or NLRP3 siRNA, and then treated with thapsigargin (TG, 0.5 mM) for
6 hr or untreated.
(G) TXNIP, IL-1b and IL-6 mRNA expression in THP-1 cells transformed with
phorbol 12-myristate 13-acetate (0.5 mM), and then treated with thapsigargin
(TG, 1 mM), tunicamycin (TM, 20 mg/ml) for 6 hr or untreated.
(H and I) THP-1 cells transformed with phorbol 12-myristate 13-acetate
(0.5 mM)were treatedwith thapsigargin (TG, 1 mM), tunicamycin (TM, 20 mg/ml),
ATP (5 mM) for 6 hr or untreated. Secreted IL-1b was measured by ELISA (H)
and caspase-1 cleavage was measured by immunoblot. P20, cleaved cas-
pase-1 (I).
n = 3; values are shown as mean ± SD. *p < 0.05, **p < 0.01, ***p < 0.001. n.s.,
not significant.
.
Figure 4. TXNIP Is an Apoptotic Component
of the Unfolded Protein Response
(A) TXNIP, caspase-3, and actin protein ex-
pression in INS-1 832/13 cells stably transduced
with pLenti-TO/shTXNIP, inducible lentivirus ex-
pressing shTXNIP. Cells were cultured with
doxycycline (Dox, 2 mg/ml) to induce shTXNIP
or without doxycycline for 48 hr, then challenged
with thapsigargin (TG, 0.05 mM) or tunicamycin
(TM, 5 mg/ml) for 24 hr. Single and double aster-
isks indicate uncleaved and cleaved caspase-3,
respectively.
(B) INS-1 832/13–TetR-shTXNIP cells were incu-
bated with doxycycline (Dox, 2 mg/ml) for 48 hr,
then treated with thapsigargin (TG, 10 nM), tuni-
camycin (TM, 5 mg/ml) for 24 hr or untreated. Cells
were stained with propidium iodide solution (PI)
followed by flow cytometry analysis. (TG, n = 6
and TM, n = 9; values are mean ± SD).
(C) Viability of INS-1 832/13-TetR-shTXNIP cells
incubated with doxycycline (Dox, 2 mg/ml) for
48 hr, and then treated with thapsigargin (TG,
50 nM) for 24 hr or untreated (n = 3; values are
mean ± SD).
(D) Human primary islets (28 year old male,
BMI 21, HbA1C 5.4) were treated with thapsi-
gargin (TG, 1 mM) in the presence of BSA
(–, 1 mg/ml) or interleukin-1 receptor antagonist
(+, 1 mg/ml) for 24 hr. Caspase 3/7 activity was
measured by Caspase-Glo 3/7 assay (triplicated,
values are shown as mean ± SD). *p < 0.05,
**p < 0.01.
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ER stress may be involved in the transcriptional activation of
IL-1b (Koenen et al., 2011). Our findings suggest that environ-
mental and genetic factors that can elicit ER stress are prom-
ising candidates for crucial factors initiating inflammation in
b cells.
It has been shown that TXNIP expression is increased by high
glucose in human islets and plays an important role in glucose
toxicity (Hui et al., 2008; Oka et al., 2009; Shalev et al., 2002;
Yoshihara et al., 2010). We have previously shown that chronic
high glucose leads to unresolvable ER stress in b cells, leading
to b cell dysfunction and death (Lipson et al., 2006; Lipson
et al., 2008). Thus, TXNIP upregulation by high glucose could
bemediated by theUPR. TXNIP has been also shown to be a crit-
ical signaling molecule linking oxidative stress to inflammasome
activation (Zhou et al., 2010). These findings, combined with
our data, indicate that a variety of stress signaling pathways
converge at TXNIP, leading to inflammasome activation and
IL-1b production.
ER stress and inflammation are critical pathogenic compo-
nents of b cell dysfunction and death in diabetes. Our data
combined with recent findings indicate that there exists a
tight link between ER stress, oxidative stress, glucose toxicity,
and inflammation, suggesting that a therapeutic strategy that
aims to target the common molecular processes that areCelaltered in stressed b cells might be effective. TXNIP provides
such a target.
EXPERIMENTAL PROCEDURES
Cell Culture
INS-1 832/13 cells were a gift from Dr. Christopher Newgard (Duke University
Medical Center). THP-1 cells were obtained from ATCC and cultured in RPMI
1640 supplemented with 10% FBS, 1 mM sodium pyruvate, and 0.05 mM
2-mercaptoethanol. These cells were transformed with phorbol 12-myristate
13-acetate (0.5 mM for 3 hr) for measurement of IL-1b secretion and cas-
pase-1 cleavage. Mouse islets were cultured in RPMI 1640 supplemented
with 5% FBS and 5 mM glucose. Human islets were cultured in CMRL media
supplemented with 5 mM glucose and grown on laminin V coated plates.
Mouse embryonic fibroblasts were maintained in Dulbecco’s modified Eagle’s
medium with 10% fetal bovine serum. Irea/ and Perk/ fibroblasts were
a gift from Dr. David Ron (University of Cambridge). Atf6a/, eIF2aS/S, and
eI2F2aA/A fibroblasts were gifts from Dr. Randal Kaufman (Sanford-Burnham
Medical Research Institute).
Lentivirus System
For generation of cells stably suppressing TXNIP, INS-1 832/13 cells were
transduced with a lentivirus expressing shRNA against rat TXNIP.
Antibodies Used for Immunoblots
Blots were probed with the following antibodies: anti-TXNIP (MBL, Nagoya,
Japan), anti-CHOP (Pierce Biotechnology, Rockford, IL), anti-eIF2a and
anti-ChREBP (Santa Cruz Biotechnology, Santa Cruz, CA), anti-caspase-1,l Metabolism 16, 265–273, August 8, 2012 ª2012 Elsevier Inc. 271
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TXNIP Is a Link between ER Stress and Inflammationanti-CREB, anti-eIF2a-P, and anti-GAPDH (Cell Signaling, Danvers, MA), and
anti-actin (Sigma-Aldrich, St. Louis, MO).
Luciferase Assay
For reporter assays, INS1 cells were cotransfected with a TXNIP promoter-
luciferase construct and various constructs as indicated. The culture medium
was changed to fresh medium with 2.5 mM glucose after 6 hr. Prior to lysis at
24 hr after transfection, cells were treated with or without 0.5 mM thapsigargin
for 6 hr. Luciferase activity was measured with a Dual-Luciferase Reporter
Assay System (Promega, Madison, WI), and transfections were normalized
with the pRL-TK vector (Promega) as an internal control.
Chromatin Immunoprecipitation
ChIP was performed using the Chromatin IP Kit (Cell Signaling, Beverly, MA)
according to the manufacturer’s instructions. The cartoon of promoter region
used for ChIP was shown in Figure S2.
Animal Experiments
Txnip knockout mice were generated as previously described (Hui et al., 2008).
All animal experiments were performed according to procedures approved by
the Institutional Animal Care and Use Committee at the University of Massa-
chusetts Medical School.
Statistical Analysis
Welch’s t test on log transformed data was used for determining the signifi-
cance between two treatments. Data are presented as the mean ± SD.
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